| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Cardiovascular Surgery (Drs. Wei, Kuukasjärvi, Laurikka, and Tarkka), the Department of Anesthesia and Intensive Care (Drs. Honkonen and Kaukinen), and the Department of Clinical Microbiology (Dr. Laine), Tampere University Hospital, Tampere, Finland.
Correspondence to: Matti Tarkka, MD, PhD, Division of Cardiovascular Surgery, Tampere University Hospital, PO Box 2000, Fin-33521 Tampere, Finland; e-mail: matti.tarkka{at}tays.fi
Objective: There are several reports of the use of adenosine as a cardioprotective agent during cardiac surgery. Adenosine treatment might affect neutrophils and inflammatory mediators. The present prospective randomized study was designed to investigate the effect of adenosine pretreatment on myocardial recovery and inflammatory response in patients undergoing elective coronary artery bypass surgery.
Design: A prospective, randomized, controlled study.
Setting: Operative unit and ICU in a university hospital in Finland.
Patients: Thirty male patients undergoing primary, elective coronary revascularization.
Interventions: Patients in the adenosine group received a 7-min infusion of adenosine (total, 650 µg/kg) before the initiation of cardiopulmonary bypass.
Measurements: Postoperative creatine kinase (CK)-MB release and hemodynamics were recorded. Perioperative leukocyte and cytokine release were measured.
Results: Adenosine pretreatment resulted in less CK-MB release and an improved postbypass cardiac index. Similar leukocyte counts and cytokine responses were seen in both groups perioperatively. Neutrophil counts were similar between the groups before and after myocardial ischemia when measured simultaneously in arterial and coronary sinus blood.
Conclusions: The present results support the hypothesis that adenosine pretreatment is cardioprotective in humans, but the present dose failed to regulate the inflammatory responses after coronary artery bypass grafting.
Key Words: adenosine • coronary artery bypass grafting • cytokine responses • myocardial injury
This article has been cited by other articles:
|
|
 |
|
  M. Wei, X. Wang, P. Kuukasjarvi, J. Laurikka, T. Rinne, E.-L. Honkonen, and M. Tarkka Bradykinin preconditioning in coronary artery bypass grafting Ann. Thorac. Surg., August 1, 2004; 78(2): 492 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Tracey, W. P. Magee, J. J. Oleynek, R. J. Hill, A. H. Smith, D. M. Flynn, and D. R. Knight Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2780 - H2787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S Wechsler and S. K Brockman Myocardial protection: an expanding or contracting discipline? Perfusion, July 1, 2003; 18(4): 213 - 217. [Abstract] [PDF]
|
|
|
|
|
|
J. Vinten-Johansen, Z.-Q. Zhao, J. S. Corvera, C. D. Morris, J. M. Budde, V. H. Thourani, and R. A. Guyton Adenosine in myocardial protection in on-pump and off-pump cardiac surgery Ann. Thorac. Surg., February 1, 2003; 75(2): S691 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vaage and G. Valen Preconditioning and cardiac surgery Ann. Thorac. Surg., February 1, 2003; 75(2): S709 - 714. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
